Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study

European Respiratory Journal

Volumn 16, Issue 3, 2000, Pages 464-471

  Mastella, G ^a   Rainisio, M ^b   Harms, H K ^c   Hodson, M E ^d   Koch, C ^e   Navarro, J ^f   Strandvik, B ^g   McKenzie, S G ^h  

^a Cystic Fibrosis Center   (Italy)

^b Statistics for Research SFR Ltd   (Switzerland)

^c UNIVERSITY OF MUNICH   (Germany)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e University of Copenhagen   (Denmark)

^f HÔPITAL ROBERT DEBRÉ   (France)

^g Oestra University Hospital   (Sweden)

^h F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Allergic bronchopulmonary aspergillosis; Cystic fibrosis; Lung function; Mixed model

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PRECIPITIN;

ADOLESCENT; ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL COLONIZATION; BRONCHOPULMONARY ASPERGILLOMA; CHILD; CYSTIC FIBROSIS; EUROPE; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HEMOPTYSIS; HUMAN; HUMAN TISSUE; HYPERSENSITIVITY; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PATHOGENESIS; PNEUMOTHORAX; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SKIN TEST;

ADOLESCENT; ADULT; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; EUROPE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFANT; MALE; MIDDLE AGE; PREVALENCE; SUPPORT, NON-U.S. GOV'T;

EID: 0033806235     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.016003464.x     Document Type: Article

References (34)

1. Allergic bronchopulmonary aspergillosis. 1: Clinical features
2. Allergic bronchopulmonary aspergillosis
3. Allergic bronchopulmonary aspergillosis
4. A pathological study of allergic bronchopulmonary aspergillosis
5. Aspergillosis and atopy in cystic fibrosis
6. Allergens as proteinases: An Aspergillus fumigatus proteinase directly induces human epithelial cell detachment
7. Allergic bronchopulmonary aspergillosis in cystic fibrosis: A secretory immune response to a colonizing organism
8. Allergic bronchopulmonary aspergillosis in cystic fibrosis
9. Cystic fibrosis and allergic bronchopulmonary aspergillosis
10. Sensitization to Aspergillus and allergic bronchopulmonary aspergillosis in a cystic fibrosis population
11. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
12. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Reported prevalence, regional distribution, and patient characteristics
13. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis
14. A 12-year longitudinal study of Aspergillus sensitivity in patients with cystic fibrosis
15. A review of allergic bronchopulmonary aspergillosis
16. ABPA in CF: A devastating combination
17. Allergic bronchopulmonary aspergillosis complicating cystic fibrosis in childhood
18. Association of allergic bronchopulmonary aspergillosis and cystic fibrosis
19. Will ABPA occur in your patient with cystic fibrosis?
20. Rise in total IgE an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis
21. Development Of immune responses to Aspergillus at an early age in children with cystic fibrosis
22. Skin test reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with cystic fibrosis
23. Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis
24. Changes in the normal maximal expiratory flow-volume curve with growth and aging
25. Random-effects models for longitudinal data
26. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis
27. The clinical spectrum of aspergillosis. 2. Epidemiology, pathogenicity, infection in animals and immunology
28. Reduction of indoor mould spores
29. Aspergillus fumigatus allergen I, is a member of the mitogillin family of cytotoxins
30. Diagnosis and management of allergic bronchopulmonary aspergillosis
31. Recombinant Aspergillus fumigatus allergens: From the nucleotide sequences to clinical applications
32. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis
33. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy